Ligand Expects 2026 Adjusted EPS of $9.50-$9.75
Ligand Pharmaceuticals expects 2026 adjusted EPS of $9.50-$9.75, versus a FactSet estimate of $9.35.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Ligand Pharmaceuticals expects 2026 adjusted EPS of $9.50-$9.75, versus a FactSet estimate of $9.35.